SeraCare

Michael K. Steele has been appointed vice president of business development, SeraCare Life Sciences, Inc. In this position, Mr. Steele will work with SeraCare’s leadership team on strategic alliances and transactions to broaden the company’s diagnostic and biopharmaceutical product portfolio. Mr. Steele will report to Susan Vogt, president and chief executive officer.
   
“We believe Michael will be a tremendous addition to the management team,” said Susan Vogt. “His extensive industry knowledge, strong leadership skills and proven track record in executing partnerships, licensing and acquisitions will play an important role in positioning SeraCare for long-term growth.”
   
“I believe the fundamentals of SeraCare are exceptionally strong and provide an excellent platform both for business development opportunities and continued growth,” said Michael Steele. “I am very pleased to have the opportunity to join the SeraCare team at such a transformational time in the Company’s history.”
   
Mr. Steele has more than 15 years of biotechnology industry experience. He held business development roles at Corautus Genetics, Inc., Life Therapeutics LTD and Serologicals Corp., and was responsible for transactions totaling more than $200 million. While at Serologicals, Mr. Steele also served in a number of operational and managerial roles.